Compounds > 2-tert-butylhydroquinone
Page last updated: 2024-08-21

2-tert-butylhydroquinone and Experimental Hepatoma

2-tert-butylhydroquinone has been researched along with Experimental Hepatoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, Y; Ma, Q; Palmiter, RD; Wood, KM1
Hirose, M; Ito, T; Miki, T; Nihro, Y; Ogiso, T; Ozaki, M; Shirai, T; Takahashi, S1
Der, CJ; Kong, AN; Lei, W; Mandlekar, S; Weber, MJ; Wu, J; Yu, R1
Hasegawa, R; Hirose, M; Hoshiya, T; Ito, N; Shirai, T; Takaba, K; Tiwawech, D1
De Long, MJ; Santamaria, AB; Talalay, P1

Other Studies

5 other study(ies) available for 2-tert-butylhydroquinone and Experimental Hepatoma

ArticleYear
Induction of metallothionein I by phenolic antioxidants requires metal-activated transcription factor 1 (MTF-1) and zinc.
    The Biochemical journal, 2004, Jun-15, Volume: 380, Issue:Pt 3

    Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cricetinae; DNA-Binding Proteins; Embryo, Mammalian; Fibroblasts; Hydroquinones; Kidney; Liver Neoplasms, Experimental; Metallothionein; Mice; NF-E2-Related Factor 2; Oxidation-Reduction; RNA, Messenger; Trans-Activators; Transcription Factor MTF-1; Transcription Factors; Transcription, Genetic; Zinc

2004
Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesi
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 1998, Volume: 7, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Antioxidants; Butylated Hydroxytoluene; DNA; Hydroquinones; Lipid Peroxidation; Liver; Liver Neoplasms, Experimental; Male; Mutagenesis; Mutagens; Propyl Gallate; Quinoxalines; Rats; Rats, Inbred F344

1998
Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals.
    The Journal of biological chemistry, 1999, Sep-24, Volume: 274, Issue:39

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Genes, Reporter; Humans; Hydroquinones; Isothiocyanates; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; NAD(P)H Dehydrogenase (Quinone); Recombinant Proteins; Signal Transduction; Sulfoxides; Thiocyanates; Tumor Cells, Cultured

1999
Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses.
    Japanese journal of cancer research : Gann, 1992, Volume: 83, Issue:5

    Topics: Animals; Antioxidants; Benzodioxoles; Body Weight; Bromodeoxyuridine; Butylated Hydroxyanisole; Catechols; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione Transferase; Hydroquinones; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Phenols; Precancerous Conditions; Rats; Rats, Inbred F344

1992
Role of cytochrome P1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants.
    Carcinogenesis, 1987, Volume: 8, Issue:10

    Topics: Animals; Cell Line; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Induction; Hydroquinones; Liver Neoplasms, Experimental; Mice; Mutation; NAD(P)H Dehydrogenase (Quinone); Naphthols; Polycyclic Compounds; Quinone Reductases; Receptors, Aryl Hydrocarbon; Receptors, Drug

1987